ROIV

Roivant Sciences Ltd. - Common Shares (ROIV)

About Roivant Sciences Ltd. - Common Shares (ROIV)

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

Details

Daily high

$39.90

Daily low

$38.72

Price at open

$39.02

52 Week High

$42.50

52 Week Low

$14.50

Market cap

28.7B

Dividend yield

Volume

5.6M

Avg. volume

10.7M

P/E ratio

-90.67

Roivant Sciences Ltd. - Common Shares News